semaglutide versus tirzepatide side effects vs Semaglutide: What's the Difference? Semaglutide vs. Tirzepatide: Mental Health
Description
Tirzepatide stands apart from other commonly prescribed weight loss medications due to its innovative dual mechanism of action

Persistent or severe gastrointestinal symptoms with signs of dehydration warrant clinical evaluation and possible laboratory assessment
Importantly, the pivotal cardiovascular and obesity outcome trials of GLP-1RAs, including the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN), Semaglutide Treatment Effect in People with obesity (STEP), and SURPASS (tirzepatide) programs, did not report clinically meaningful increases in AITD or sustained thyroid dysfunction [7,8,30]
Tirzepatide, a synthetic peptide composed of 39 amino acids, functions as a dual receptor agonist of both the GIP and GLP-1 receptors
Heres how it typically looks: Weeks 1 through 4: 2.5 mg weekly (starting dose) Weeks 5 through 8: 5 mg weekly Weeks 9 through 12: 7.5 mg weekly Weeks 13 through 16: 10 mg weekly Weeks 17 and beyond: 12.5 mg or 15 mg weekly (if needed) Each dose increase happens in 2.5 mg increments, and you stay at each level for at least four weeks before moving up
